Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Kodaz, Hilmi"'
Autor:
Inal, Ali1, Kodaz, Hilmi2, Odabas, Hatice3, Duran, Ayse4, Seker, Mehmet5, İnanc, Mevlide6, Elkıran, Emin7, Gunaydın, Yusuf8, Menekse, Serkan9, Topcu, Turkan10, Urakcı, Zuhat11, Tastekin, Didem12, Bilici, Mehmet13, Cihan, Sener14, Geredeli, Caglayan15, Sezer, Emel16, Uncu, Dogan17, Arpacı, Erkan18, Ozturk, Banu19, Bal, Oznur20
Publikováno v:
Journal of Cancer Research & Therapeutics. Apr-Jun2018, Vol. 14 Issue 3, p578-582. 5p.
Autor:
Bal, Oznur, ELKIRAN, EMİN TAMER, Gunaydin, Yusuf, Menekse, Serkan, Topcu, Turkan Ozturk, Urakci, Zuhat, Tastekin, Didem, BİLİCİ, Mehmet, Cihan, Sener, UYSAL, MÜKREMİN, TANRIVERDİ, ÖZGÜR, Gumus, Mahmut, Ustaalioglu, Bala Basak Oven, Suner, Ali, Cokmert, Suna, Hacibekiroglu, Ilhan, Aydin, Kubra, Isikdogan, Abdurrahman, Inal, Ali, Kodaz, Hilmi, Geredeli, Caglayan, SEZER, EMEL, Uncu, Dogan, Arpaci, Erkan, Ozturk, Banu, Odabas, Hatice, Duran, Ayse Ocak, Seker, Mehmet Metin, Inanc, Mevlide
Publikováno v:
American Journal of Rhinology & Allergy. 32:132-138
WOS: 000432900700002 PubMed ID: 29644886 Background: Mometasone furoate, one of the second generation intranasal corticosteroids, is currently used in suspension form due to its poor solubility. However, this is not favorable for nasal application be
Autor:
Kodaz, Hilmi1 hilmikodaz@hotmail.com, Taştekin, Ebru2, Erdoğan, Bülent1, Hacıbekiroğlu, İlhan1, Tozkır, Hilmi3, Gürkan, Hakan3, Türkmen, Esma1, Demirkan, Bora3, Uzunoğlu, Sernaz1, Çiçin, İrfan1
Publikováno v:
Balkan Medical Journal. Jul2016, Vol. 33 Issue 4, p407-410. 4p.
Autor:
Kostek, Osman, Yilmaz, Erdem, Bekir Hacioglu, Erdogan, Bulent, Kodaz, Hilmi, Bekmez, Esma Turkmen, Hacibekiroglu, Ilhan, Uzunoglu, Sernaz, Tuncbilek, Nermin, Cicin, Irfan
Publikováno v:
Web of Science
Efficient and adequate evaluation of therapeutic response in hepatocellular carcinoma (HCC) is an evolving field. We aimed to evaluate apparent diffusion coefficient (ADC) values in the prediction of response to sorafenib and prognosis in patients wi
Autor:
HACIBEKIROGLU, ILHAN1 ilhanhbo@hotmail.com, KODAZ, HILMI1, ERDOGAN, BULENT1, TURKMEN, ESMA1, ESENKAYA, ASIM2, ONAL, YILMAZ3, UZUNOGLU, SERNAZ1, CICIN, IRFAN1
Publikováno v:
Molecular & Clinical Oncology. Sep/Oct2015, Vol. 3 Issue 5, p1160-1164. 5p.
Publikováno v:
Turkish Journal of Oncology / Türk Onkoloji Dergisi. 2015, Vol. 30 Issue 2, p25-33. 9p.
Autor:
KODAZ, HILMI1 hilmikodaz@hotmail.com, HACIBEKIROGLU, ILHAN1, ERDOGAN, BULENT1, TURKMEN, ESMA1, TOZKIR, HILMI2, ALBAYRAK, DOGAN3, UZUNOGLU, SERNAZ1, CICIN, IRFAN1
Publikováno v:
Molecular & Clinical Oncology. 2015, Vol. 3 Issue 1, p179-184. 6p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
KODAZ, Hilmi
Publikováno v:
Volume: 6, Issue: 1 1-4
Kocaeli Tıp Dergisi
Kocaeli Tıp Dergisi
GİRİŞ ve AMAÇ: Akciğer kanseri dünyada en sık görülen ve en ölümcül kanserlerden biridir. Sigara içmenin süresi ve miktarının akciğer kanseri gelişiminde etkin bir rol oynadığı bilinmektedir. Akciğer kanserleri genelde orta iler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::f289549a370c23eaefb1528d0bc6e6a2
https://dergipark.org.tr/tr/pub/kotder/issue/38612/448103
https://dergipark.org.tr/tr/pub/kotder/issue/38612/448103
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.